LO News 61.21 07/31/2014 05:23:49 Lorillard Inc (LO)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Lorillard Inc (LO) 61.21 $LO

Lorillard e-cig revenue drops
at Investor's Business Daily - Wed Jul 30, 6:08PM CDT
The tobacco company's Q2 EPS rose 4% to 84 cents, missing views by 5 cents. Revenue dipped 1.4% to $1.27 bil, under views for $1.34 bil as sales of e-cigarettes fell 35% to $37 mil on increased competition. Overall cigarette shipments fell 3%;...

Lorillard's (LO) Q2 Earnings Miss Estimates, Sales Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 30, 11:14AM CDT
Cigarette maker Lorillard Inc. (LO) reported adjusted earnings of 84 cents per share in the second quarter of quarter 2014, up 3.7% from the prior-year quarter.

Drop in e-cigarette sales hurts Lorillard profit
By MICHAEL FELBERBAUM - AP - Wed Jul 30, 10:58AM CDT
RICHMOND, Va. (AP) — Newport maker Lorillard Inc.'s profit fell 4.2 percent in the second quarter as sales of its market-leading Blu electronic cigarettes dropped and it sold fewer cigarettes.

Lorillard, Inc. Reports Second Quarter Results
PR Newswire - Wed Jul 30, 6:00AM CDT
Lorillard, Inc. (NYSE: LO) announced today its results for the quarter ended June 30, 2014.

Reynolds' Q2 earnings fire up
at Investor's Business Daily - Tue Jul 29, 6:05PM CDT
The tobacco giant's profit rose 7% to 89 cents a share, beating by 2 cents, as higher prices helped offset falling sales volume. Revenue fell 1% to $2.16 bil vs. views for $2.22 bil. Reynolds American (RAI) plans to buy rival Lorillard (LO) for $25...

Lorillard Rises 1.65% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Jul 29, 4:34PM CDT
Lorillard (NYSE:LO) traded in a range yesterday that spanned from a low of $60.58 to a high of $61.73. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $61.19 on volume of 3.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

After Yesterday's Rally of 1.65% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Jul 29, 4:33PM CDT
Lorillard (NYSE:LO) traded in a range yesterday that spanned from a low of $60.58 to a high of $61.73. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $61.19 on volume of 3.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Reynolds Q2 Earnings Beats on Estimates; Tightens FY14 View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 29, 11:00AM CDT
Reynolds American Inc.'s (RAI) adjusted earnings of 89 cents per share in the second quarter of fiscal 2014 beat the Zacks Consensus Estimate of 87 cents by 2.3%.

Lorillard Has Returned 17.1% Since SmarTrend Recommendation (LO)
Comtex SmarTrend(R) - Tue Jul 29, 9:27AM CDT
SmarTrend identified an Uptrend for Lorillard (NYSE:LO) on March 3rd, 2014 at $51.92. In approximately 5 months, Lorillard has returned 17.10% as of today's recent price of $60.79.


Reynolds American 2Q profit climbs 6.7 percent
By MICHAEL FELBERBAUM - AP - Tue Jul 29, 9:25AM CDT
RICHMOND, Va. (AP) — Reynolds American Inc. said Tuesday that its profit rose by 6.7 percent in its second quarter as higher cigarette and smokeless tobacco prices helped to offset a decline in the number of cigarettes it sold.

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Lorillard, Inc. in Connection with the Sale of the Company
Business Wire - Mon Jul 28, 5:35PM CDT
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Lorillard, Inc. ("Lorillard" or the "Company" (NYSE: LO) relating to the proposed acquisition by Reynolds American, Inc. ("Reynolds".

How Will Lorillard (LO) Stock Be Affected By This Price Target Increase?
at The Street - Mon Jul 28, 8:01AM CDT
Lorillard (LO) was upgraded to 'neutral' by analysts at Nomura (NMR) who also raised their price target to $64 on Monday.

Upgrade Alert for Lorillard (LO)
Comtex SmarTrend(R) - Mon Jul 28, 6:58AM CDT
Lorillard (NYSE:LO) was upgraded from Reduce to Neutral at Nomura today. The stock closed yesterday at $60.73 on volume of 1.7 million shares, below average daily volume of 4.8 million. Lorillard share prices have moved between a 52-week high of $67.46 and a 52-week low of $41.56 and closed yesterday at 46% above that low price at $60.73 per share. Over the past week, the 200-day moving average (MA) has gone up 0.7% while the 50-day MA has advanced 0.3%.

Judge's New Menthol Ruling Could Help Lift Tobacco Merger
Rich Duprey, The Motley Fool - Motley Fool - Sat Jul 26, 8:00AM CDT
Source: Wikimedia Commons As part of making the $27 billion megamerger between tobacco giants Lorillard and Reynolds American work, the two agreed to calve off a number of cigarette brands to Imperial Tobacco Group in a separate $7 billion...

Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Lorillard, Inc. Stockholders
Business Wire - Wed Jul 23, 12:56PM CDT
Kirby McInerney LLP is investigating potential claims against Lorillard, Inc. ("Lorillard" or the "Company" (NYSE: LO) concerning the proposed acquisition of the Company by Reynolds American, Inc. ("Reynolds" (NYSE: RAI). Under the terms of the definitive merger agreement, Lorillard stockholders will receive $50.50 in cash and 0.2909 shares of Reynolds common stock for each share of Lorillard common stock they own, valuing the deal at approximately $27 billion.

Reynolds American Gets Burned in Tobacco Lawsuit
Rich Duprey, The Motley Fool - Motley Fool - Tue Jul 22, 9:00AM CDT
Source: Wikimedia Commons. It's a good thing Imperial Tobacco Group had an indemnity clause inserted when it agreed to  buy a bunch of cigarette brands from Reynolds American and Lorillard to smooth those companies' merger. Because...


Marlboro maker Altria's 2Q profit stays flat
AP - Tue Jul 22, 8:58AM CDT
RICHMOND, Va. (AP) — Marlboro maker Altria Group posted flat second-quarter earnings Tuesday as higher prices helped to offset decline in the number of cigarettes it sold.

Judge: FDA can't use tobacco panel menthol report
By MICHAEL FELBERBAUM - AP - Mon Jul 21, 7:43PM CDT
RICHMOND, Va. (AP) — The Food and Drug Administration can't use an advisory panel's 2011 report on menthol cigarettes because its members had conflicts of interest, a federal judge ruled Monday.

Lorillard Shares Up 17.5% Since SmarTrend's Buy Recommendation (LO)
Comtex SmarTrend(R) - Mon Jul 21, 5:20PM CDT
SmarTrend identified an Uptrend for Lorillard (NYSE:LO) on March 3rd, 2014 at $51.92. In approximately 5 months, Lorillard has returned 17.50% as of today's recent price of $61.00.

Reynolds Drops On Jury Award As Merger Questioned
at Investor's Business Daily - Mon Jul 21, 5:17PM CDT
Tobacco giant Reynolds American (RAI) stumbled Monday on news that a Florida jury awarded the widow of a long-time smoker who died of lung cancer a $23.6 billion verdict. The verdict, handed down last Friday, hit most tobacco stocks. The Tobacco...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Viatris Declares Quarterly Dividend Amid Acquisition Buzz

Updated Category News Views 65

A Dividend Declaration with a Side of Mergers Viatris, the healthcare giant operating on a global scale, has been making some noise recently. On the surface, it's another quarterly dividend—$0.12 per share, set to hit the pockets of shareholders on December 16. But there's a lot more cooking under the hood of this announcement that ticks just about every box for a...

Continue Reading
Lululemon Faces Lawsuit Over Alleged Fraudulent Reporting

Updated Category News Views 110

What's Stirring the Pot for Lululemon? Talk about a rollercoaster. Over here, Lululemon (NASDAQ:LULU) is navigating turbulent waters, facing a class action lawsuit for alleged securities fraud. Investors who bought into the brand between March 18, 2026, and September 3, 2026, are now watching their investments drop, following what's claimed as misleading trumpet calls...

Continue Reading
Greenberg Traurig's Stars Shine in Delaware's Legal Scene

Updated Category News Views 56

Five Lawyers, One Prestigious List Eating lunch today, I nearly dropped my sandwich when I read that five top-notch attorneys from Greenberg Traurig have snagged spots on Delaware Today's 2026 Top Lawyers List. This isn't your everyday pat on the back; it's Delaware, the heavyweight champ of corporate law, after all. The Legal Eagles of Greenberg Traurig Kicking off this...

Continue Reading
Samsung Ups Stake in TCL CSOT: A Game-Changer?

Updated Category News Views 137

Samsung Electronics' Strategic Play Sometimes it takes a gutsy move to shake up the industry, and Samsung Electronics just went for it. Snagging a 10.16% stake in TCL CSOT isn't just some run-of-the-mill acquisition. It's a calculated chess piece placement in the cutthroat display tech arena. Unpacking the Stake Game This latest move shifts Samsung Display's stake to...

Continue Reading
Black Friday Doubt Grows: Just 54% Trust Real Deals

Updated Category News Views 93

Do Shoppers Believe in Black Friday Anymore? You'd think by now, retailers would have cracked the code on building trust with their customers. But guess what? A fresh survey from Boston Consulting Group reveals only 54% of consumers buy the whole Black Friday discount story. That's barely more than flipping a coin. Promotion Fatigue: The Trust Buster Funny thing,...

Continue Reading
LULU Under Fire: Class Action Opportunities Await

Updated Category News Views 138

Lululemon Faces a Legal Storm If you're holding shares in Lululemon (NASDAQ: LULU), you might want to sit up and pay attention. Schall, Brown & Schwartz LLP, a national shareholder rights litigation firm, is gathering folks for a securities fraud class action lawsuit against Lululemon. They're pointing fingers at the company for cooking the books – or at least not being...

Continue Reading
Askey & Icom Team Up: Trading Airwaves for Partnerships

Updated Category News Views 20

Old-School Radios Meet Cutting-Edge 5G When I hear about a company linking their old-school tech with shiny new 5G jazz, skepticism kicks in fast. But then comes this announcement: Askey and Icom America are joining forces to bring 5G networks with integrated two-way radio systems to various sectors—like a classic combo meal with a tech twist. The key audience? Utility...

Continue Reading
Sectra Powers Radiology at Mount Sinai with AI Integration

Updated Category News Views 97

AI and Radiology: A Match Made for Mount Sinai Today, we're diving into a technological leap that promises to shake up the healthcare sector—Sectra's integration of artificial intelligence with radiology at Mount Sinai Health System. The deal pairs Sectra's prowess in medical imaging IT and cybersecurity with the healthcare giant in New York, aiming to redefine how...

Continue Reading
DarioHealth Taps Palumbo to Drive Healthcare Evolution

Updated Category News Views 32

Strategic Leadership for an Evolving Market Prepare your portfolios, folks. DarioHealth Corp. (NASDAQ:DRIO) is gearing up to ride a seismic shift in healthcare. John R. Palumbo's appointment as Chairman of the Board marks a bold move as Dario looks to dominate the new convergence of consumer-directed and payer-funded healthcare. This isn't just a change of guard; it's a...

Continue Reading
Atlas-SSI Expands Grip in Water Control Space

Updated Category News Views 191

Atlas-SSI Makes Waves with Linita Acquisition Here's the kind of news that makes an old market hound sit up and take notice. Atlas-SSI, the big cheese in North America for water management solutions, has gone and snagged Linita Design & Manufacturing. Why's this worth talking about? Linita isn't just any player—they've been crafting custom-engineered hydro-mechanical...

Continue Reading

Top 5 Most Recently Viewed Articles

Medicenna Reveals Promising MDNA11 Results at SITC Meeting

Updated Category News Views 197

Medicenna's Groundbreaking MDNA11 Updates Medicenna Therapeutics Corp., a clinical-stage immunotherapy company, recently made headlines at a prominent annual meeting dedicated to cancer research. Their innovative approach using MDNA11, a long-acting interleukin-2 super-agonist, is showing significant promise, particularly in the context of advanced solid tumors that have...

Continue Reading
Melco Resorts Restructures Operations for Future Growth

Updated Category News Views 267

Melco Resorts Announces Strategic Changes to Casino Operations Recent developments from Melco Resorts & Entertainment Limited (Nasdaq: MLCO) signal a significant shift in the company's operational strategy. The company, known for its luxurious integrated resort facilities across Asia and Europe, has made the difficult decision to cease operations at the Grand Dragon...

Continue Reading
Verizon Highlights Surge in Cyber Threats in Latest Report

Updated Category News Views 489

Insights from Verizon's 2025 Data Breach Investigations Report In a pivotal revelation, Verizon Business has issued its latest Data Breach Investigations Report, shedding light on an unsettling surge in system intrusions affecting organizations across the Asia-Pacific region. The report emphasizes that a staggering 80% of reported data breaches can be traced back to these...

Continue Reading
BrookBridge Wealth Transitions to LPL Private Wealth Management

Updated Category News Views 109

BrookBridge Private Wealth Joins LPL Financial BrookBridge Private Wealth has officially joined LPL Financial, a move designed to deepen client service and widen what the firm can offer. By aligning with LPL, the team can focus on high-net-worth clients while keeping the personalized, one-to-one approach that defines their work. The transition gives them room to tailor...

Continue Reading
Breckenridge Expands Product Line with Everolimus Approval

Updated Category News Views 225

Breckenridge Announces FDA Approval for Everolimus Tablets In an impressive stride towards enhancing healthcare accessibility, Breckenridge Pharmaceutical, Inc., the U.S. subsidiary of Towa International, recently revealed the final FDA approval for Everolimus Tablets for Oral Suspension (TFOS). This generic medication, available in 2mg, 3mg, and 5mg doses, serves as a...

Continue Reading